Menu Back toAddressing-the-Elephant-in-the-Room-A-Hard-Look-at-Metrics-Legal-Payers-and-Other-Leading-Obstacles-Facing-the-Sustainability-of-Patient-Engagement

DIA 2018 Global Annual Meeting

Addressing the Elephant in the Room: A Hard Look at Metrics, Legal, Payers, and Other Leading Obstacles Facing the Sustainability of Patient Engagement

    Session Chair(s)
      Katherine  Capperella

      Katherine Capperella

      • Global Patient Engagement Leader
      • Janssen Pharmaceutical Companies of Johnson & Johnson, United States
    As the industry continues to evolve and incorporate the patient’s voice into drug development - ultimately toward the stage of regular and continuous integrative collaboration - this session will discuss how it’s essential to openly assess and discuss common topics and challenges that may impact the long-term sustainability of patient engagement.
    Learning Objective : Identify the needs of private payers when defining the value of healthcare treatments and interventions; Describe the legal, regulatory and compliance considerations that biopharmaceutical companies must address to develop and execute sustainable, ethical and compliant patient engagement initiatives; Explore methodologies that biopharmaceutical companies are using to measure internal changes related to regularly, efficiently, and successfully implementing patient-centric solutions.